Toripalimab Combined with Chemoradiotherapy for Locally Advanced Cervical Squamous Cell Carcinoma Patients: Early Results of Safety and Feasibility

D. Ou,R. Cai,W. X. Qi,J. Y. Chen,H. P. Xu

SSRN Electronic Journal（2023）

引用 0|浏览4

暂无评分

摘要

Toripalimab combined with CCRT achieved good tolerance and demonstrated promising anti-tumor effects in patients with locally advanced cervical cancer. Longer follow-up results and further phase Ⅱ/Ⅲ studies are expected. Chinese Clinical Trial Registry number, ChiCTR2000032879.

查看译文

关键词

chemoradiotherapy,squamous cell carcinoma,toripalimab combined

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要